Medcamp S.A.
Medcamp S.A. operates in Real Estate Development.
Medcamp S.A. (MDP) - Net Assets
Latest net assets as of June 2024: zł4.22 Million PLN
Based on the latest financial reports, Medcamp S.A. (MDP) has net assets worth zł4.22 Million PLN as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł5.00 Million) and total liabilities (zł786.88K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł4.22 Million |
| % of Total Assets | 84.27% |
| Annual Growth Rate | -23.06% |
| 5-Year Change | -78.91% |
| 10-Year Change | N/A |
| Growth Volatility | 30.29 |
Medcamp S.A. - Net Assets Trend (2016–2022)
This chart illustrates how Medcamp S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medcamp S.A. (2016–2022)
The table below shows the annual net assets of Medcamp S.A. from 2016 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | zł10.93 Million | -36.77% |
| 2021-12-31 | zł17.29 Million | -11.03% |
| 2020-12-31 | zł19.44 Million | +24.88% |
| 2019-12-31 | zł15.56 Million | -69.98% |
| 2018-12-31 | zł51.85 Million | -1.72% |
| 2017-12-31 | zł52.76 Million | +0.16% |
| 2016-12-31 | zł52.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medcamp S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 268.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | zł55.62 Million | 508.65% |
| Total Equity | zł10.93 Million | 100.00% |
Medcamp S.A. Competitors by Market Cap
The table below lists competitors of Medcamp S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Printcare PLC
CM:CAREN0000
|
$1.97K |
|
Chicken Soup for the Soul Entertainment, Inc.
NASDAQ:CSSEQ
|
$1.97K |
|
BEC WORLD -F-
MU:BW7
|
$1.97K |
|
Brinx Resources Ltd
PINK:BNXR
|
$1.97K |
|
ATTITUDE PROPERTY LTD
SEM:APL
|
$1.97K |
|
PINE CLIFF ENERGY
BE:IPC
|
$1.97K |
|
NEL Hydrogen ASA
ST:NELO
|
$1.97K |
|
Minh Khang Capital Trading Public JSC
VN:CTP
|
$1.96K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medcamp S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 17,292,712 to 10,934,544, a change of -6,358,168 (-36.8%).
- Net loss of 5,532,740 reduced equity.
- Other factors decreased equity by 825,428.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-5.53 Million | -50.6% |
| Other Changes | zł-825.43K | -7.55% |
| Total Change | zł- | -36.77% |
Book Value vs Market Value Analysis
This analysis compares Medcamp S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.50x to 2.13x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | zł0.60 | zł0.89 | x |
| 2020-12-31 | zł0.74 | zł0.89 | x |
| 2021-12-31 | zł0.66 | zł0.89 | x |
| 2022-12-31 | zł0.42 | zł0.89 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medcamp S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -50.60%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.11x
- Recent ROE (-50.60%) is below the historical average (-39.70%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.01% | 134.00% | 0.00x | 1.05x | zł-5.26 Million |
| 2017 | 0.07% | 491.88% | 0.00x | 1.05x | zł-5.24 Million |
| 2018 | -1.75% | -25.95% | 0.06x | 1.06x | zł-6.09 Million |
| 2019 | -233.15% | -1814335.00% | 0.00x | 1.15x | zł-37.84 Million |
| 2020 | 19.92% | 0.00% | 0.00x | 1.18x | zł1.93 Million |
| 2021 | -12.39% | -21431.12% | 0.00x | 1.14x | zł-3.87 Million |
| 2022 | -50.60% | 0.00% | 0.00x | 1.11x | zł-6.63 Million |
Industry Comparison
This section compares Medcamp S.A.'s net assets metrics with peer companies in the Real Estate Operations industry.
No peer company data available for comparison.